Belgravia Medical Piotr Grabowski sp. k. (Poland)

Main Activities: Offices of Dentists

Secondary Activities: Medical Equipment and Supplies Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Pharmacies and Drug Stores | Cosmetics, Beauty Supplies, and Perfume Stores | Lessors of Real Estate | All Other Miscellaneous Schools and Instruction | All Other Miscellaneous Ambulatory Health Care Services

Full name: Belgravia Medical Piotr Grabowski sp. k.

Profile Updated: May 21, 2024

Belgravia Medical Piotr Grabowski sp. k. is based in Poland, with the head office in Kielce. The company operates in the Offices of Dentists sector. It was first established on September 26, 2022. In 2025, the company reported a net sales revenue increase of 15.04%. There was a total growth of 51.32% in Belgravia Medical Piotr Grabowski sp. k.’s total assets over the same period. The net profit margin of Belgravia Medical Piotr Grabowski sp. k. increased by 1.95% in 2025.

Headquarters
Ul. Karbonska 1
Kielce; Swietokrzyskie; Postal Code: 25-640

Contact Details: Purchase the Belgravia Medical Piotr Grabowski sp. k. report to view the information.

Basic Information

Financial Auditors:

Purchase the Belgravia Medical Piotr Grabowski sp. k. report to view the information.

Incorporation Date:

September 26, 2022

Key Executives

Purchase this report to view the information.

Associate Partner

Purchase this report to view the information.

Limited Partner

Company Performance

Financial values in the chart are available after Belgravia Medical Piotr Grabowski sp. k. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

15.04%▲

Total Operating Revenue

15.04%▲

Operating Profit

22.26%▲

EBITDA

21.88%▲

Net Profit/Loss for the Period

22.47%▲

Total Assets

51.32%▲

Total Equity

44.72%▲

Operating Profit Margin

2.09%▲

Net Profit Margin

1.95%▲

Return on Equity (ROE)

-13.42%▼

Quick Ratio

-3.55%▼

Cash Ratio

-3.45%▼

Similar companies